Related Experiment Video
Updated: Jun 29, 2025

Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung
Published on: November 16, 2021
Identification of Siglec-1-negative alveolar macrophages with proinflammatory phenotypes in chronic obstructive
Takuya Saito1, Naoya Fujino1, Yorihiko Kyogoku1
1Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
Abstract:
Alveolar macrophages (AMs) in patients with chronic obstructive pulmonary disease (COPD) orchestrate persistent inflammation in the airway. However, subpopulations of AMs participating in chronic inflammation have been poorly characterized. We previously reported that Siglec-1 expression on AMs, which is important for bacteria engulfment, was decreased in COPD. Here, we show that Siglec-1-negative AMs isolated from COPD lung tissues exhibit a proinflammatory phenotype and are associated with poor clinical outcomes in patients with COPD. Using flow cytometry, we segregated three subsets of AMs based on the expression of Siglec-1 and their side scattergram (SSC) and forward scattergram (FSC) properties: Siglec-1+SSChiFSChi, Siglec-1-SSChiFSChi, and Siglec-1-SSCloFSClo subsets. The Siglec-1-SSCloFSClo subset number was increased in COPD. RNA sequencing revealed upregulation of multiple proinflammatory signaling pathways and emphysema-associated matrix metalloproteases in the Siglec-1-SSCloFSClo subset. Gene set enrichment analysis indicated that the Siglec-1-SSCloFSClo subset adopted intermediate phenotypes between monocytes and mature alveolar macrophages. Functionally, these cells produced TNF-α, IL-6, and IL-8 at baseline, and these cytokines were significantly increased in response to viral RNA. The increase in Siglec-1-negative AMs in induced sputum is associated with future exacerbation risk and lung function decline in patients with COPD. Collectively, the novel Siglec-1-SSCloFSClo subset of AMs displays proinflammatory properties, and their emergence in COPD airways may be associated with poor clinical outcomes.NEW & NOTEWORTHY Alveolar macrophages (AMs) in patients with chronic obstructive pulmonary disease (COPD) orchestrate persistent inflammation in the airway. We find that Siglec-1-negative alveolar macrophages have a wide range of proinflammatory landscapes and a protease-expressing phenotype. Moreover, this subset is associated with the pathogenesis of COPD and responds to viral stimuli.
Insights
Siglec-1-negative alveolar macrophages (AMs) with a proinflammatory phenotype are increased in chronic obstructive pulmonary disease (COPD). This subset is linked to disease severity and lung function decline in COPD patients.
Area of Science:
- Immunology
- Pulmonology
- Cell Biology
Background:
- Alveolar macrophages (AMs) drive airway inflammation in chronic obstructive pulmonary disease (COPD).
- Subpopulations of AMs involved in COPD pathogenesis remain poorly understood.
- Siglec-1 expression, crucial for bacterial engulfment, is reduced in COPD AMs.
Purpose of the Study:
- To characterize Siglec-1-negative AM subpopulations in COPD.
- To investigate the phenotype and clinical relevance of these AM subsets.
- To determine the association of Siglec-1-negative AMs with COPD progression and outcomes.
Main Methods:
- Flow cytometry to isolate AM subsets based on Siglec-1 expression and scatter properties (SSC/FSC).
- RNA sequencing to analyze gene expression profiles of identified subsets.
- Cytokine analysis to assess inflammatory responses.
- Correlation analysis with clinical data including exacerbation risk and lung function.
Main Results:
- A Siglec-1-negative, low scatter (Siglec-1-SSCloFSClo) AM subset was increased in COPD patients.
- This subset exhibited upregulated proinflammatory pathways and matrix metalloproteases.
- Siglec-1-negative AMs produced significant levels of TNF-α, IL-6, and IL-8, with heightened responses to viral RNA.
- Increased Siglec-1-negative AMs in sputum correlated with future exacerbation risk and lung function decline.
Conclusions:
- A novel Siglec-1-negative AM subset (Siglec-1-SSCloFSClo) displays a proinflammatory phenotype in COPD.
- This subset exhibits intermediate characteristics between monocytes and mature AMs.
- The emergence of this proinflammatory AM subset is associated with COPD pathogenesis and poor clinical outcomes.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Inflammation

